RxDoctor Payments Data

Brian Bethea, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Delray Beach, FLNPI 1417002908

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.5%), other and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 56.9% of the total. Reporting peaked in 2021 at $67,815 and has fallen 99.2% since, to $509 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$329,557in general payments, 2019–2025

Across 393 payments — averaging $838.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$188K
  • Angiodynamics, Inc.$89K
  • Edwards Lifesciences$31K
  • Livanova USA, Inc.$12K
  • Medtronic$6K
  • Boston Scientific$2K
  • plus $2K from 6 others
$1,522,661in research payments, 2019–2025

Across 221 payments — averaging $6889.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$1.4M
  • Medtronic$92K
  • Boston Scientific$2K

What the payments were for

  • Consulting fees$169,70051%
  • Speaking & faculty fees$15,3505%
  • Travel & lodging$42,09713%
  • Food & beverage$13,2434%
  • Other$89,16727%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$329,557 in reported general payments places this provider in the 95th percentile of 408 thoracic surgery (cardiothoracic vascular surgery) providers in Florida.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Florida

Medicare billing

Part B allowed, 2024
$388,094
Medicare patients
262
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium14$127
Atorvastatin Calcium11$72
ClopidogrelClopidogrel Bisulfate11$71

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Delray Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →